HT and CVD prevention. from myth to reality.
Menopausal hormone therapy has no evidence-based role for the primary or secondary prevention of coronary heart disease. Coronary prevention should involve lifestyle and pharmacologic interventions documented as beneficial in randomized clinical trials and promulgated in national guidelines.
Wenger
Nanette K
NK
Emory University School of Medicine, Atlanta, GA 30303, USA. nwenger@emory.edu
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D004348:Drug Labeling; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008019:Life Style; D008593:Menopause; D011372:Progestins; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration; D016387:Women's Health
D011372:Progestins